VYXEOS (daunorubicin/cytarabine liposomal)
ANTHRACYCLINE ANTIBIOTICS·ACUTE MYELOID LEUKEMIA·+1
JAZZ PHARMACEUT
Indication
Acute myeloid leukemia with myelodysplasia-related changes
Acute myeloid leukemia with myelodysplasia-related changes is an aggressive hematologic malignancy characterized by the clonal proliferation of poorly differentiated myeloid precursors affecting the bone marrow and peripheral blood. Read more about Acute myeloid leukemia with myelodysplasia-related changes
1 drugs 1 manufacturers
Drugs that treat it
Common Acute myeloid leukemia with myelodysplasia-related changes therapies.
Filter & compare in the drug finder →Opens the drug finder with Acute myeloid leukemia with myelodysplasia-related changes preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute myeloid leukemia with myelodysplasia-related changes is an aggressive hematologic malignancy characterized by the clonal proliferation of poorly differentiated myeloid precursors affecting the bone marrow and peripheral blood.
Primarily diagnosed in older adults, it is clinically defined by at least 20% blasts in the blood or bone marrow alongside evidence of myelodysplasia.
Diagnostic criteria require at least one of the following: a documented history of myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasm, specific myelodysplasia-associated cytogenetic abnormalities, or multilineage dysplasia involving at least 50% of cells across two or more hematopoietic cell lineages.
Pathophysiologically, this disease subtype demonstrates severe hematopoietic dysfunction, profound cytopenias, frequent resistance to standard chemotherapy, and a generally poor prognosis.
- nih.gov
Acute myeloid leukemia with myelodysplasia-related changes is an aggressive hematologic malignancy characterized by the clonal proliferation of poorly differentiated myeloid precursors affecting the bone marrow and peripheral blood Primarily diagnosed in older adults, it is clinically defined by at least 20% blasts in the blood or bone marrow alongside evidence of myelodysplasia Diagnostic criteria require at least one of the following: a documented history of myelodysplastic syndrome or myelody...
- nih.gov
Acute myeloid leukemia with myelodysplasia-related changes is an aggressive hematologic malignancy characterized by the clonal proliferation of poorly differentiated myeloid precursors affecting the bone marrow and peripheral blood
- cancer.gov
Primarily diagnosed in older adults, it is clinically defined by at least 20% blasts in the blood or bone marrow alongside evidence of myelodysplasia Diagnostic criteria require at least one of the following: a documented history of myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasm, specific myelodysplasia-associated cytogenetic abnormalities, or multilineage dysplasia involving at least 50% of cells across two or more hematopoietic cell lineages Pathophysiologically, this ...
- nih.gov
Pathophysiologically, this disease subtype demonstrates severe hematopoietic dysfunction, profound cytopenias, frequent resistance to standard chemotherapy, and a generally poor prognosis
- atlasgeneticsoncology.org
Pathophysiologically, this disease subtype demonstrates severe hematopoietic dysfunction, profound cytopenias, frequent resistance to standard chemotherapy, and a generally poor prognosis
Personalize your experience
Follow Acute myeloid leukemia with myelodysplasia-related changes and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.